---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-076282"
form_type: "8-K12B"
ticker: "KNSA"
cik: "0001730430"
company_name: "Kiniksa Pharmaceuticals International, plc"
filed_at: "2024-06-28T23:59:59+00:00"
generated_at: "2026-06-01T00:43:01.545797+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Kiniksa completes redomiciliation from Bermuda to UK, shares trade on Nasdaq under same symbol KNSA

## Summary
- Effective June 27, 2024, Kiniksa redomiciled to UK via Bermuda court-approved scheme of arrangement.
- Shareholders received one-for-one exchange of shares; ~40.4M Class A, 1.8M B, 12.8M A1, 16.1M B1 ordinary shares issued.
- Class A Ordinary Shares continue trading on Nasdaq under symbol KNSA as of June 28, 2024.
- Same executive officers and directors continue; indemnification agreements and equity plans assumed.
- Depositary receipts issued for shares not directly eligible for DTC transfer to avoid UK stamp duty.

## SEC filing metadata
- accession: 0001104659-24-076282
- form_type: 8-K12B
- ticker: KNSA
- cik: 0001730430
- company_name: Kiniksa Pharmaceuticals International, plc
- filed_at: 2024-06-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.01, 3.02, 3.03, 5.03, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1730430/000110465924076282/0001104659-24-076282-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1730430/000110465924076282/tm2417839d12_8k12b.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-076282
- JSON: https://secwatch.observer/filing/0001104659-24-076282.json
- Plain text: https://secwatch.observer/filing/0001104659-24-076282.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.